Pro Medicus (OTCMKTS:PMCUF) Trading Up 0.2% – Should You Buy?

Pro Medicus Limited (OTCMKTS:PMCUF) shares were up 0.2% during trading on Thursday . The company traded as high as $89.32 and last traded at $89.32. Approximately 25 shares traded hands during mid-day trading, a decline of 96% from the average daily volume of 629 shares. The stock had previously closed at $89.1142.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group set a $155.00 target price on Pro Medicus and gave the stock a “buy” rating in a report on Thursday, February 12th. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $155.00.

Pro Medicus Price Performance

The business has a 50 day simple moving average of $91.98 and a 200 day simple moving average of $118.25.

Pro Medicus Company Profile

Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.

The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.